Year archive

ROQUEFORT THERAPEUTICS PLC — 2023 filings

All 33 regulatory filings released by ROQUEFORT THERAPEUTICS PLC (ROQ) in 2023, sourced directly from the official regulator.

33 Filings

2023 Period

2023 filings (33)

Filing	Released	Lang
Change of Auditor Audit Report / Information FY 2023	2023-11-24	English
Significant Mesodermal Killer Cell Milestone Regulatory Filings	2023-11-06	English
Interim Results to 30 June 2023 Interim / Quarterly Report H1 2023	2023-09-27	English
Investor Presentation via Investor Meet Company Report Publication Announcement	2023-09-22	English
Expansion of Patent Portfolio Regulatory Filings	2023-08-14	English
Development of New Novel siRNA Therapeutics Share Issue/Capital Change	2023-08-07	English
Director/PDMR Shareholding Director's Dealing	2023-08-02	English
Director/PDMR Shareholding Director's Dealing	2023-07-12	English
Results of AGM AGM Information	2023-06-29	English
AGM Statement AGM Information	2023-06-29	English
Investor Presentation via Investor Meet Company Report Publication Announcement	2023-06-27	English
Director/PDMR Shareholding Director's Dealing	2023-06-26	English
Director/PDMR Shareholding Director's Dealing	2023-06-26	English
Director/PDMR Shareholding Director's Dealing	2023-06-26	English
RNA Medicine Shows In Vitro Anti-Cancer Efficacy Earnings Release Q2 2023	2023-06-22	English
Antibody Program Results & Orphan Drug Indication Regulatory Filings	2023-06-19	English
Anti-Cancer MDK mRNA - Positive in vitro Results Regulatory Filings	2023-06-13	English
Restoration of Trading Report Publication Announcement	2023-06-07	English
Annual Report & Financial Statements Annual Report (ESEF) FY 2022	2023-06-06	English
Notice of Annual General Meeting AGM Information	2023-06-06	English
Annual Report & Financial Statements Annual Report FY 2022	2023-06-05	English
Annual Report & Financial Statements - 31 Dec 2022 Audit Report / Information FY 2022	2023-06-05	English
Suspension of Trading Pending 2022 Annual Report Report Publication Announcement	2023-05-02	English
Confirmation of No Exposure to Silicon Valley Bank Regulatory Filings	2023-03-13	English
Creation of New Novel Family of mRNA Therapeutics Regulatory Filings	2023-03-08	English
Formation of Scientific Advisory Board Board/Management Information	2023-03-06	English
Company Presentation Regulatory Filings	2023-03-01	English
Investor Presentation Report Publication Announcement	2023-02-21	English
Randox Licence and Royalty Agreement Regulatory Filings	2023-02-20	English
MDK Oncology Antibodies Demonstrate In-Vivo Safety Regulatory Filings	2023-01-24	English
Holding(s) in Company Major Shareholding Notification	2023-01-18	English
Appointment of Auditor Board/Management Information	2023-01-16	English
Operations Update Regulatory Filings	2023-01-09	English